Followers | 35 |
Posts | 6308 |
Boards Moderated | 0 |
Alias Born | 02/09/2015 |
Saturday, March 12, 2016 3:55:57 PM
What a weird stock: unsure how often there has ever been such a stock.
In development currently, about to start phase 2 studies, is a potentially revolutionary cancer drug that could be in widespread use around the world for many cancers. There is a game changing mostly gram pos antibacterial that has already proven that it works as well as the best potential alternative, but with much greater ease of administration.(And without resistance!??!??) And this same antibiotic appears to have antiinflammatory properties that might work against mucositis(certainly some hints we will hear good news with B-OM).
Not only that, CTIX has a potentially very useful treatment for large numbers of psoriasis patients.
This inventory does not include a potential gm negative drug, or other possible uses for Brilacidin for proctitis or external otitis or conjunctivitis.
And while all of this is true, you can reach into your pocket, and pull out some change and buy a share, and the stock is traded in oblivion, and its products have all the visibility of dark matter. It languishes in obscurity in the pink sheets at just over a dollar as of early spring 2016.
Where will we be in 2020? What a story. What potential.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM